Topical treatments are the mainstay of the treatment of psoriasis of the scalp, with the vehicle as well as the active ingredient relevant to efficacy, tolerability and compliance. Topical corticosteroids remain the mainstay in the treatment of scalp psoriasis. Numerous topical and systemic therapies are available for the treatment of the cutaneous manifestations of psoriasis. Corticosteroids Topical corticosteroids remain the mainstay of topical psoriasis treatment despite the development of newer agents 19. Topical therapies remain the mainstay of psoriasis treatment; however, these are associated with additional challenges where preparations may be perceived as messy, inconvenient and time-consuming.
Genetic connections have been made between psoriasis and other diseases, including atopic dermatitis, rheumatoid arthritis, and Crohn’s disease. Despite the importance of systemic therapies and recent advances represented by biologic agents, topical treatments will probably remain the mainstay of psoriasis therapy for most patients. Topical therapies remain the mainstay of psoriasis treatment; however, heightened awareness of psoriasis as a systemic disorder has led to greater use of both conventional and biological systemic agents. The superpotent topicals are often used as an adjunct to systemic therapy and will likely remain a mainstay of psoriasis therapy.
In spite of advances represented by biologics, topical treatment will probably remain the mainstay of psoriasis therapy for most patients (4) but; unfortunately there is no unique curative systemic or topical treatment for the disease. You should get strong relief from topical corticosteroids for psoriasis. Topical steroids remain a mainstay of treatment for inflammatory skin conditions, including psoriasis, said Christopher G. Steroid treatments that work initially may lose their effectiveness over time as your body develops a resistance to them.